Clinical Trial Update: Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2 [Phase 2]

View source ↗

Summary

Phase 2 studies evaluating influenza vaccine and tetanus-pneumococcal vaccine in HIV-infected patients receiving interleukin-2 have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Influenza vaccine (influenza vaccine)
• Interleukin-2 (interleukin-2)
• Tetanus-Pneumococcal vaccine (tetanus-pneumococcal vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED